What is 21 CFR Part 820 and its relevance to medical devices?

• A. It is the U.S. Quality System Regulation governing design, manufacturing, and quality systems for medical devices, including documentation and process controls.
• B. It is a European quality system regulation.
• C. It regulates advertising and labeling for medical devices.
• D. It regulates clinical trial reporting.

Answer: (C)

21 CFR Part 820 is the FDA’s Quality System Regulation for medical devices in the United States. It requires manufacturers to establish and maintain a comprehensive quality management system that governs the entire device lifecycle—from design to production to servicing. The focus is on building quality into processes, with design controls to ensure a device meets user needs and intended use, and with production and process controls, CAPA (corrective and preventive actions), and document controls to keep records and evidence of decisions. It also covers purchasing controls, handling, labeling, storage, and distribution controls, as well as management responsibility and resources for maintaining the system. The regulatory aim is to ensure devices marketed in the US are safe and effective, and it is enforced through FDA inspections and potential enforcement actions. This is distinct from European quality systems (like CE marking and ISO 13485) and from regulations governing advertising, labeling, or clinical trial reporting, which fall under other parts of the regulations.